Board approves $300 million stock buyback expansion
Shows the company has extra cash and confidence, returning money to shareholders through repurchases.
Hinge Health, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 5 Aug 2026Shows the company has extra cash and confidence, returning money to shareholders through repurchases.
Company is confident enough to raise expectations for earnings, signaling business is growing faster than before.
New board members help guide company decisions; Sloat brings finance experience from Freshworks and Zuora.
Quarterly earnings show how well the company performed; investors use this to evaluate if stock price is fair.
Quarterly earnings show how well the company performed; investors use this to evaluate if stock price is fair.
New leadership with CFO experience at Freshworks and Zuora strengthens board oversight of company finances.
Annual earnings report shows total company performance; required filing that guides long-term investor decisions.
Stocky reads Hinge Health, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Hinge Health, Inc.'s most recent tracked filing was a 8-K on 4 Aug 2026: Board approves $300 million stock buyback expansion.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.